94. Primary sclerosing cholangitis Clinical trials / Disease details
Clinical trials : 148 / Drugs : 118 - (DrugBank : 39) / Drug target genes : 18 - Drug target pathways : 141
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01161992 (ClinicalTrials.gov) | March 2002 | 12/7/2010 | Genomics of Primary Sclerosing Cholangitis (PSC) | P.R.O.G.R.E.S.S.: PSC Resource Of Genetic Risk, Environment and Synergy Studies. | Primary Sclerosing Cholangitis (PSC) | Genetic: Genetic Analysis | Mayo Clinic | NULL | Active, not recruiting | 5 Years | 90 Years | All | 1500 | United States |